EPO Patents = 1

Forward Citations = 45

Loading Chart...

5 inventors (with patents filed for the assignee):

Hiroyuki Mano (6 out of 12 patents)

Sadao Kuromitsu (6 out of 9 patents)

Nobuaki Shindo (6 out of 12 patents)

4. Takatoshi Soga (6 out of 10 patents)

5. Takashi Furutani (6 out of 16 patents)

6 patents: Sort by Forward Citations

1. 9932589 - EML4-ALK fusion gene (2018-04-03),

2. 9029521 - EML4-ALK fusion gene (2015-05-12),

3. 8197818 - EML4-ALK fusion gene (2012-06-12),

4. 7964710 - EML4-ALK fusion gene (2011-06-21),

5. 7728120 - EML4-ALK fusion gene (2010-06-01),

6. 7605131 - EML4-ALK fusion gene (2009-10-20),

Curegene K.k. is a leading biotechnology company dedicated to developing innovative gene therapies for various genetic disorders and rare diseases. With a team of experienced researchers and scientists, Curegene is at the forefront of gene therapy research and development, striving to improve the lives of patients and families around the world.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

6 Patents

#2,217 in Tokyo

#5,842 in Japan

Tokyo, Japan

Curegene K.k.